Legal Representation
Attorney
Britt L. Anderson
USPTO Deadlines
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 2, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 2, 2025 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 2, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 25, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 23, 2025 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| May 23, 2025 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Feb 27, 2025 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 27, 2025 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
| Feb 27, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 22, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Feb 21, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Feb 21, 2025 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Jan 30, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 29, 2025 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Jan 26, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Nov 15, 2024 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Nov 15, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 17, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 16, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| May 16, 2024 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| May 16, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 9, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 7, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Nov 7, 2023 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Nov 7, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 18, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 16, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 16, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| May 16, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Nov 18, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 16, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Nov 16, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Nov 16, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 23, 2022 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| May 17, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 22, 2022 | CHPB | I | POST PUBLICATION AMENDMENT - ENTERED | Loading... |
| Apr 21, 2022 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
| Apr 11, 2022 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED | Loading... |
| Mar 22, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 22, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 2, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 16, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 15, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 14, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 14, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 17, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 17, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 17, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 16, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 29, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 005
Gene therapy products, namely, custom donor genetic material in the nature of human cells for use in genome modification; Biological preparations for use in the genetic treatment of pathological medical conditions, namely, cancer, neurological diseases, autoimmune diseases, and genetic disorders
First Use Anywhere:
Sep 30, 2024
First Use in Commerce:
Sep 30, 2024
Classification
International Classes
005